 
                    
                Quratis Inc.
Develops infectious disease vaccines and offers biologics CDMO services for global health.
348080 | KO
Overview
Corporate Details
- ISIN(s):
- KR7348080003
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 의료단지길 143 -, 청주시
- Website:
- https://www.quratis.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Quratis Inc. is a biopharmaceutical company specializing in the development of innovative vaccines for infectious diseases and providing advanced biologics manufacturing services. The company's R&D pipeline focuses on next-generation vaccines for global health threats, including tuberculosis (TB), COVID-19, and other neglected tropical diseases. In addition to its proprietary development, Quratis operates as a Contract Development and Manufacturing Organization (CDMO), leveraging its state-of-the-art GMP-certified facilities. It offers comprehensive bench-to-field support, from research and process optimization to commercial-scale production, with expertise in platforms such as mRNA-LNP drug delivery. Through strategic global partnerships, Quratis aims to deliver high-quality, accessible, life-saving solutions worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-13 00:00 | Interim Report 반기보고서 (2025.06) | Korean | 1.0 MB | ||
| 2025-06-20 00:00 | Major Shareholding Notification 주식등의대량보유상황보고서(일반) | Korean | 179.5 KB | ||
| 2025-06-19 00:00 | Regulatory News Service 신규시설투자등               | Korean | 7.5 KB | ||
| 2025-05-15 00:00 | Quarterly Report 분기보고서 (2025.03) | Korean | 1.0 MB | ||
| 2025-05-09 00:00 | Regulatory News Service 조회공시요구(현저한시황변동)에대한답변(중요정보없음)               | Korean | 4.7 KB | ||
| 2025-05-08 00:00 | Regulatory News Service 조회공시요구(현저한시황변동)               | Korean | 3.5 KB | ||
| 2025-05-07 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.1 KB | ||
| 2025-05-07 00:00 | Major Shareholding Notification 주식등의대량보유상황보고서(일반) | Korean | 183.5 KB | ||
| 2025-04-17 00:00 | Annual Report [기재정정]사업보고서 (2024.12) | Korean | 1.6 MB | ||
| 2025-04-08 00:00 | Annual Report [기재정정]사업보고서 (2023.12) | Korean | 1.5 MB | ||
| 2025-04-07 00:00 | Audit Report / Information 사업보고서 (2024.12) | Korean | 492.3 KB | ||
| 2025-04-07 00:00 | Audit Report / Information 감사보고서제출               | Korean | 19.1 KB | ||
| 2025-04-07 00:00 | Post-Annual General Meeting Information [기재정정]정기주주총회결과               | Korean | 31.5 KB | ||
| 2025-04-07 00:00 | Audit Report / Information [기재정정]감사보고서제출               | Korean | 36.6 KB | ||
| 2025-03-31 00:00 | Post-Annual General Meeting Information 정기주주총회결과               | Korean | 18.7 KB | 
Automate Your Workflow. Get a real-time feed of all Quratis Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Quratis Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Quratis Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    